Regeneron v. Mylan – Update On Aflibercept BPCIA Litigation - Patent
As we have previously reported, Regeneron's BPCIA case against Mylan regarding Mylan's proposed aflibercept biosimilar is proceeding on an expedited schedule
Stay updated with breaking news from Ship Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As we have previously reported, Regeneron's BPCIA case against Mylan regarding Mylan's proposed aflibercept biosimilar is proceeding on an expedited schedule
The USPTO extended the backup PDF option for docx filers from June 30, 2023 to the new date of January 17, 2024. A link to the Federal Register final rule can be found here.
The front page of every patent lists the person or people responsible for inventing the patented idea. When the invention is made by a single person, inventorship is straightforward –...
The Federal Circuit has reversed the District of Delaware's ruling that added an inventor to a patent. The Federal Circuit found that the contribution by the added inventor was not significant...
The Federal Circuit has reversed the District of Delaware’s ruling that added an inventor to a patent. The Federal Circuit found that the contribution by the added inventor was not...